Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: Unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients

Transplantation Proceedings

Volumn 37, Issue 9, 2005, Pages 3738-3742

  Morales, J M ^a   Andres A ^a   Dominguez Gil, B ^a   Arriola, M ^a   Gutierrez M J ^a   Hernandez E ^a   Ortuno T ^a   Praga, M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MONOTHERAPY; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; CREATININE; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 29544451714     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.09.178     Document Type: Conference Paper

References (11)

1. D.B. Kaufman, R. Shapiro, M.R. Lucey Immunosuppression practice and trends Am J Transplant 4 suppl 9 2004 38
2. A.D. Mayer, J. Dmitrewski, J.P. Squifflet Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection a report of the European Tacrolimus Multicenter Renal Study Group Transplantation 64 1997 436
3. A.D. Mayer European Tacrolimus Multicentre Renal Study Group Chronic rejection and graft half-life five-year follow-up of the European tacrolimus multicenter renal study Transplant Proc 34 2002 1491
4. B.J. Nankivell, R.J. Borrows, C.L. Fung Calcineurin inhibitor nephrotoxicity longitudinal assesment by protocolo histology Transplantation 78 2004 557
5. B.J. Nankivell, R.J. Borrows, C.L. Fung The natural history of chronic allograft nephropathy N Engl J Med 11 2003 2326 349
6. I.H. Klein, A. Abrahams, T. van Ede Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects Transplantation 73 2002 732
7. F. Vincenti, S.C. Jensik, R.S. Filo A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation evidence for improved allograft survival at five years Transplantation 73 2002 775
8. E. Varo, E. Padin, E. Otero Cardiovascular risk factors in liver allograft recipients relationship with immunosuppressive therapy Transplant Proc 34 2002 1553
9. B.J. Nankivell, R.J. Borrows, C.L. Fung Natural history, risk factors, and impact of subclinical rejection in kidney transplantation Transplantation 78 2004 242
10. F. Vincenti, S.C. Jensik, R.S. Filo A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation evidence for improved allograft survival at five years Transplantation 73 2002 1370
11. M.A. Artz, J.M.M. Boots, G. Ligtenberg Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile Am J Transplant 4 2004 937